Brief: Takara Bio USA And BioSyntagma Develop Method For Large-Scale Automated COVID-19 Testing

Takara Bio

08/06/2020 13:16

June 8 (Reuters) - Takara Bio Inc  4974.T :
    * TAKARA BIO USA, INC. AND BIOSYNTAGMA, INC. DEVELOP METHOD
FOR
LARGE-SCALE AUTOMATED COVID-19 TESTING

Source text for Eikon:  ID:nBw75px2xa 
Further company coverage:  4974.T 

 ((Reuters.Briefs@thomsonreuters.com;))